| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $509,719 | -2,424 | -0.04% | $210.28 | 5,755,806 | 15 Dec 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $1,252,701 | -5,959 | -0.1% | $210.22 | 5,749,847 | 16 Dec 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $210.5425. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $211.175. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |